The #BIOCONVERGENCE revolution is here, and we’re proud to be leading the charge. Today, we embarked on our transition to BICO (formerly CELLINK), a new business structure concentrating on the intersection of biology and technology. Since our founding in 2016, we’ve built one of the world’s most expansive portfolio of life science products, and this change will enable BICO and its 11 subsidiaries to innovate like never before.
CYTENA is proud to be a part of the Bioconvergence revolution and are committed
Learn more about our movement, visit bico.com
